Drug Shortage Report for GALANTAMINE ER
| Report ID | 219378 |
| Drug Identification Number | 02443015 |
| Brand name | GALANTAMINE ER |
| Common or Proper name | GALANTAMINE ER |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALANTAMINE |
| Strength(s) | 8MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-02-12 |
| Actual start date | 2024-02-12 |
| Estimated end date | 2024-04-05 |
| Actual end date | 2024-04-03 |
| Shortage status | Resolved |
| Updated date | 2024-04-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-04-04 | English | Compare |
| v6 | 2024-04-03 | French | Compare |
| v5 | 2024-04-03 | English | Compare |
| v4 | 2024-03-12 | French | Compare |
| v3 | 2024-03-12 | English | Compare |
| v2 | 2024-02-13 | French | Compare |
| v1 | 2024-02-13 | English | Compare |
Showing 1 to 7 of 7